About
MacuLogix develops the AdaptDx Pro, a medical device that enhances the early diagnosis and management of dry Age-related Macular Degeneration (AMD) through advanced dark adaptation testing. This next-generation dark adaptometer is a lightweight, self-contained headset that measures retinal function by assessing how well the eye adapts to darkness, a crucial indicator for early AMD detection. The AdaptDx Pro features an onboard AI virtual technician named Theia, which guides patients through the testing process with automated instructions. This design allows for quick and objective measurements of rod-mediated dark adaptation, completing tests in under 10 minutes. The device is particularly beneficial for eye care professionals, including optometrists and ophthalmologists, as it streamlines workflow and reduces the need for technician involvement. It is especially valuable for clinics focused on early intervention for patients over 50, who are at a higher risk for AMD.
Technologies
Keywords
Company Information
-
Employees 8
-
Total Funding $38700000
Location
1000 Kreider Dr, Middletown, Pennsylvania, United States, 17057-3113
